Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 2/20 | 0.38 |
| ▸ | DDR2 | Q16832 | 2/20 | 0.38 |
| ▸ | RAF1 | P04049 | 14/20 | 0.36 |
| ▸ | BRAF | P15056 | 13/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.34 |
| ▸ | BTK | Q06187 | 1/20 | 0.34 |
| ▸ | RARB | P10826 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12573758 | 1.00 | FGFR1 (0.38) | FGFR1DDR2RAF1BRAFMAPK14 | |
| SCHEMBL1332389 | 0.95 | FGFR1 (0.35) | FGFR1DDR2RAF1BRAFBTK | |
| SCHEMBL9968003 | 0.95 | FGFR1 (0.35) | FGFR1DDR2RAF1BRAFBTK | |
| SCHEMBL2015558 | 0.91 | FGFR1 (0.34) | FGFR1DDR2RAF1BRAFBTK | |
| SCHEMBL12634342 | 0.91 | FGFR1 (0.34) | FGFR1DDR2RAF1BRAFBTK | |
| SCHEMBL12573754 | 0.89 | MAPT (0.35) | RAF1 | |
| SCHEMBL1332426 | 0.89 | MAPT (0.35) | RAF1 | |
| SCHEMBL29910319 | 0.88 | NPC1 (0.34) | FGFR1DDR2RAF1BRAFMAPK14 | |
| SCHEMBL1331933 | 0.88 | NPC1 (0.34) | FGFR1DDR2RAF1BRAFMAPK14 | |
| SCHEMBL9973017 | 0.87 | RAF1 (0.34) | FGFR1DDR2RAF1BRAFMAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2652552-B9 | PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS | TRANSITIONS OPTICAL INC (US) | 2016-02-17 | — | — | EP | disclosed |
| EP-2652552-B1 | PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS | TRANSITIONS OPTICAL INC (US) | 2015-09-02 | — | — | EP | disclosed |
| US-8545984-B2 | Photochromic compounds and compositions | TRANSITIONS OPTICAL, INC. (US) | 2013-10-01 | — | — | US | disclosed |
| US-20110129678-A1 | Photochromic compounds and compositions | TRANSITIONS OPTICAL, INC. (US) | 2011-06-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110129678-A1 | Photochromic compounds and compositions | CRY2, CRY1, PPOX | FGFR1 3270/4885DDR2 1349/4885RAF1 3185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.